Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
0.8579
-0.0397 (-4.42%)
Range 0.85 - 0.94
Open 0.89
Prev Close 0.8976
52 Week 0.80 - 2.06
Volume 5123311
Market Cap 441.7M
*Delayed 12/19/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000